
MacroGenics Inc
NASDAQ:MGNX

Intrinsic Value
The intrinsic value of one
MGNX
stock under the Base Case scenario is
2.14
USD.
Compared to the current market price of 1.36 USD,
MacroGenics Inc
is
Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
MacroGenics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
MacroGenics Inc
Balance Sheet Decomposition
MacroGenics Inc
Current Assets | 182.1m |
Cash & Short-Term Investments | 154.1m |
Receivables | 10.5m |
Other Current Assets | 17.4m |
Non-Current Assets | 42.5m |
PP&E | 41m |
Other Non-Current Assets | 1.5m |
Free Cash Flow Analysis
MacroGenics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
MacroGenics Inc
Revenue
|
154.1m
USD
|
Cost of Revenue
|
-15.6m
USD
|
Gross Profit
|
138.5m
USD
|
Operating Expenses
|
-201.7m
USD
|
Operating Income
|
-63.2m
USD
|
Other Expenses
|
7.4m
USD
|
Net Income
|
-55.8m
USD
|
MGNX Profitability Score
Profitability Due Diligence
MacroGenics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Score
MacroGenics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
MGNX Solvency Score
Solvency Due Diligence
MacroGenics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Score
MacroGenics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MGNX Price Targets Summary
MacroGenics Inc
According to Wall Street analysts, the average 1-year price target for
MGNX
is 4.28 USD
with a low forecast of 2.02 USD and a high forecast of 8.4 USD.
Dividends
Current shareholder yield for MGNX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MGNX
stock under the Base Case scenario is
2.14
USD.
Compared to the current market price of 1.36 USD,
MacroGenics Inc
is
Undervalued by 36%.